1
Enquiry period
with 12.10.2026 16:29
to 16.10.2026 16:30
3 days left
2
Bidding period
with 16.10.2026 16:30
to 20.10.2026 09:00
3
Auction
21.10.2026 14:00
4
Evaluation

5
Contract

Status Enquiry period
Estimated value without VAT 45 745,90 MDL
Period of clarifications: 12 Oct 2026, 16:29 - 16 Oct 2026, 16:30
Submission of proposals: 16 Oct 2026, 16:30 - 20 Oct 2026, 9:00

Supplier technical support:

(+373) 79999801

Advertising
Subscribe
Advertising

În scopul atribuirii contractelor subsecvente (pentru anul 2027) ca urmare a acordului-cadru din 29 iulie 2024 încheiat prin procedura de achiziție publică nr. ocds-b3wdp1-MD-1718720327664 din 28.06.2024 privind “Achiziționarea medicamentelor necesare pentru realizarea Programului Național Epidermoliza buloasă, pentru anul 2025-2027”

Information about customer
Fiscal code/IDNO
Address
MD-2005, MOLDOVA, mun.Chişinău, locality, mun. Chișinău MD-2005, bd. Grigore Vieru, 22/2
Web site
---
The contact person
Full name
Chirtoca Marina
Contact phone
+37322222490
Purchase data
Date created
12 Oct 2026, 14:27
Date modified
12 Oct 2026, 16:29
Achizitii.md ID
21691849
CPV
33600000-6 - Produse farmaceutice
Type of procedure
Request price offers (goods)
Award criteria
The lowest price
Funding sources
Advertising
Documents of the procurement procedure
Propunerea tehnică
Technical Specifications
Propunerea tehnică
12.10.26 16:29
Propunerea financiară
Technical Specifications
Propunerea financiară
12.10.26 16:29
Model contract subsecvent
Bidding Documents
Model contract subsecvent
12.10.26 16:29
Acord Cadru PN Epidermoliza Buloasa Corect.semnat.signed
Bidding Documents
Acord Cadru PN Epidermoliza Buloasa Corect.semnat.signed
12.10.26 16:29
Declaratie privind valabilitatea ofertei model
Bidding Documents
Declaratie privind valabilitatea ofertei model
12.10.26 16:29
declarație (1)
Bidding Documents
declarație (1)
12.10.26 16:29
Invitatie pentru reofertare 2027 epidermoliza.signed
Bidding Documents
Invitatie pentru reofertare 2027 epidermoliza.signed
12.10.26 16:29
Question's name
Question
Only authorized platform users may ask questions during the clarification period.